View all studies | Type 2 Diabetes - Summit Health

Type 2 Diabetes Research Study

This research study is evaluating the safety and effectiveness of an investigational drug in people with Type 2 Diabetes.

The study may be an option if you:

  •  Are 18 years of age or older
  • Have been diagnosed with Type 2 Diabetes
  • Have a BMI of ≥ 25 kg/m2
  • Are on a stable daily dose(s) of any of the following:
    • Any metformin formulations ≥1500 mg or maximum tolerated or effective dose.
    • Any metformin combination formulation ≥1500 mg or maximum tolerated or effective dose. The treatment can be with or without SGLT-2 inhibitors.
    • Are being treated with once-daily basal insulin (e.g. insulin glargine U100 or U300, NPH insulin, insulin detemir, insulin degludec) ≤ 40 units/day for ≥ 90 days before screening.
  • Other criteria apply.

The study may last up to 47 weeks, consisting of a 2-week screening period followed by a randomization visit, a 40-week treatment period and a follow-up period of 5 weeks. Qualified participants may receive the study drug and will receive study-related evaluations and care at no cost. Financial compensation will also be provided for time and travel expenses. You will receive $50 for each completed scheduled visit and $25 for any unscheduled visits that may occur.

Submit to learn more: 

When you register your interest with Accellacare, our clinical research specialists will review your information at no cost and connect you with studies you may be eligible for. When we find a match, Accellacare may contact you for further pre-screening or we may share your information with a local site office for them to contact you directly. Your data will be processed as outlined in the Accellacare privacy policy

Data Protection

As the data controller for the Accellacare.us, Accellacare is committed to protecting the information that you provide. Where you give us your consent, we may use your information to: (a) identify appropriate clinical trials for you and to let you know about them; and/or (b) send you invitations to participate in future study opportunities. You can withdraw your consent at any time, but we may continue some limited processing where we have other legal grounds for doing so.

Please enter the security code:


Please note: You may or may not benefit medically from taking part and you are able to opt out at anytime and do not have to give us a reason for doing so. Your primary care physician will be informed about your participation and all medical assessments that will be carried out as part of the study. If during screening any abnormal results are found your primary care physician will also be informed.